IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,057,674 | -8.3% | 34,375,000 | -7.1% | 0.73% | -6.3% |
| Q2 2023 | $37,148,608 | +67.6% | 37,010,000 | +68.2% | 0.78% | +76.6% |
| Q1 2023 | $22,162,113 | +70.5% | 22,000,000 | +83.3% | 0.44% | +41.9% |
| Q4 2022 | $12,996,787 | +4.5% | 12,000,000 | -2.7% | 0.31% | +8.8% |
| Q3 2022 | $12,434,000 | -18.3% | 12,334,000 | -14.4% | 0.28% | -16.9% |
| Q2 2022 | $15,218,000 | +29.4% | 14,416,000 | +38.4% | 0.34% | +49.8% |
| Q1 2022 | $11,756,000 | +1.7% | 10,416,000 | 0.0% | 0.23% | -5.4% |
| Q4 2021 | $11,561,000 | -6.1% | 10,416,000 | 0.0% | 0.24% | -14.5% |
| Q3 2021 | $12,314,000 | +0.8% | 10,416,000 | 0.0% | 0.28% | +6.8% |
| Q2 2021 | $12,212,000 | +5.8% | 10,416,000 | 0.0% | 0.26% | -10.8% |
| Q1 2021 | $11,544,000 | -1.2% | 10,416,000 | 0.0% | 0.30% | -9.7% |
| Q4 2020 | $11,690,000 | +12.2% | 10,416,000 | -0.8% | 0.33% | -17.3% |
| Q3 2020 | $10,422,000 | – | 10,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,675,000 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,052,000 | $11,459,000 | 0.69% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 14,416,000 | $15,218,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,767,000 | $29,301,000 | 0.29% |
| AQR Arbitrage LLC | 5,200,000 | $5,486,000 | 0.12% |
| CSS LLC/IL | 2,500,000 | $2,635,000 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,700,000 | $18,674,000 | 0.09% |
| Jefferies Group LLC | 10,096,000 | $10,674,524 | 0.09% |
| Daiwa Securities Group Inc. | 5,000,000 | $5,261,000 | 0.04% |
| Calamos Advisors LLC | 7,500,000 | $7,910,000 | 0.03% |